{"transactions":[{"id":671700,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":18226,"kind":"person","name":"Cicala Peter","position":1,"cik":"0002011534","reported_name":"Cicala Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2026-09-02T01:56:12.000Z","date":"2026-08-31","kind":"grant","planned":false,"acquired":true,"shares":5083,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents options to purchase shares of the registrant's common stock in lieu of prorated director's cash compensation for 2026 pursuant to the Director's Compensation Plan effective August 15, 2026, granted under the Issuer's 2026 Omnibus Equity Incentive Plan. Subject to continued service, 100% of the stock options will vest on December 31, 2026."}],"balance_after":5083,"derivative":{"exercise_price":4.57,"expiration_date":"2036-08-31","underlying":"Common Stock","underlying_shares":5083},"source":{"system":"sec-edgar","filing":"0001493152-26-041135","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315226041135/ownership.xml","form_type":"4"}},{"id":671699,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":18226,"kind":"person","name":"Cicala Peter","position":1,"cik":"0002011534","reported_name":"Cicala Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2026-09-02T01:56:12.000Z","date":"2026-08-31","kind":"grant","planned":false,"acquired":true,"shares":5943,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to continued service, one-third of the shares underlying the stock option will vest on the first anniversary of the grant date, and the remaining shares underlying the stock option will vest in 24 substantially equal monthly installments thereafter."}],"balance_after":5943,"derivative":{"exercise_price":4.57,"expiration_date":"2036-08-31","underlying":"Common Stock","underlying_shares":5943},"source":{"system":"sec-edgar","filing":"0001493152-26-041135","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315226041135/ownership.xml","form_type":"4"}},{"id":1278029,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":18226,"kind":"person","name":"Cicala Peter","position":1,"cik":"0002011534","reported_name":"Cicala Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2025-02-11T00:00:08.000Z","date":"2025-02-07","kind":"grant","planned":false,"acquired":true,"shares":51485,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to continued service, one-third of the shares underlying the stock option will vest on the first anniversary of the grant date, and the remaining shares underlying the stock option will vest in 24 substantially equal monthly installments thereafter."}],"balance_after":51485,"derivative":{"exercise_price":0.34,"expiration_date":"2035-02-07","underlying":"Common Stock","underlying_shares":51485},"source":{"system":"sec-edgar","filing":"0001493152-25-005719","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315225005719/ownership.xml","form_type":"4"}},{"id":1534304,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":18226,"kind":"person","name":"Cicala Peter","position":1,"cik":"0002011534","reported_name":"Cicala Peter","relationship":{"director":true}}],"security":"Stock Option (Right to buy)","published_at":"2024-04-29T20:31:01.000Z","date":"2024-04-26","kind":"grant","planned":false,"acquired":true,"shares":88946,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option shall vest as to 100% of the number of shares subject to the stock option on the one-year anniversary of the grant date."}],"balance_after":88946,"derivative":{"exercise_price":1.74,"expiration_date":"2034-04-26","underlying":"Common Stock","underlying_shares":88946},"source":{"system":"sec-edgar","filing":"0001140361-24-023013","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000114036124023013/form4.xml","form_type":"4"}}]}